RECRUITING

Childhood Cancer Survivors' Affective Response to Exercise

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective of this study is to assess the feasibility of administering the Personalized Single-Category Implicit Association Test (PSC-IAT) to young adult survivors of childhood cancer. Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.

Official Title

Childhood Cancer Survivors' Affective Response to Exercise

Quick Facts

Study Start:2023-03-22
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05763290

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 39 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants enrolled in St. Jude Lifetime Cohort (SJLIFE) aged 18-39 years at completion of on campus visit
  2. * Primary diagnosis of acute lymphoblastic leukemia (ALL)
  3. * No cranial radiation therapy (CRT) as part of treatment for ALL
  4. * Identify as physically inactive (do not meet Centers for Disease Control and Prevention (CDC) guidelines of 150 minutes of moderate physical activity per week or 75 minutes of vigorous physical activity per week)
  5. * Women who are not currently pregnant
  1. * Individuals who cannot speak, read, and/or understand English.
  2. * Individuals with an estimated IQ of \<70 and/or per PI discretion
  3. * Individuals with any contraindication to stress testing (i.e. cardiovascular complications)
  4. * Women who are currently pregnant

Contacts and Locations

Study Contact

Megan Ware, MS, PhD
CONTACT
866-278-5833
referralinfo@stjude.org
Kirsten Ness, PhD
CONTACT
866-278-5833
referralinfo@stjude.org

Principal Investigator

Megan Ware, MS, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Deo Srivastava, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Lisa Jacola, PhD, ABPP-CN2
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Rachel Webster, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Tara Brinkman, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Kevin Krull, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Melissa Hudson, MD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Leslie Robinson, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital

Study Locations (Sites)

St. Jude Children's Research Hospital
Memphis, Tennessee, 38105
United States

Collaborators and Investigators

Sponsor: St. Jude Children's Research Hospital

  • Megan Ware, MS, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Deo Srivastava, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Lisa Jacola, PhD, ABPP-CN2, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Rachel Webster, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Tara Brinkman, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Kevin Krull, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Melissa Hudson, MD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital
  • Leslie Robinson, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-22
Study Completion Date2025-12

Study Record Updates

Study Start Date2023-03-22
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • ALL, Childhood
  • Acute Lymphoblastic Leukemia